Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly is a research paper published in Journal of the Endocrine Society (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL12002
National Heart, Lung, and Blood Institute
Grant: HL120760
National Institute of Child Health and Human Development
Grant: HD098872
DRC at Washington University
Grant: P30 DK020579
National Center for Advancing Translational Sciences
Grant: UL1TR000448
NIDDK NIH HHS
Grant: R01 DK112921
NHLBI NIH HHS
Grant: R01 HL149853
NHLBI NIH HHS
Grant: R33 HL120760
NIDDK NIH HHS
Grant: P30 DK056341
NHLBI NIH HHS
Grant: R21 HL120760
NICHD NIH HHS
Grant: R21 HD098872
NCATS NIH HHS
Grant: UL1 TR002345
National Institutes of Health
Grant: 5R21HD098872-02
Signaling mechanisms and mouse models for insulin-mediated pseudoacromegaly
National Institutes of Health
Grant: 5R21HL120760-02
Lipidomic Screening For Functional Surfactant Gene Mutations
National Institutes of Health
Grant: 4UL1TR000448-10
Washington University Institute of Clinical and Translational Sciences
National Institutes of Health
Grant: 2P30DK020579-36
Diabetes Research Center
Children's Discovery Institute
National Institutes of Health
Saigh Foundation
FWCI
0.57
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals